Fundraising FoxMerand Pharmaceuticals
Charlottesville, US · Founded 2018 · Delaware corporation
Find your way into Merand Pharmaceuticals
Sign up to see every warm intro you have to Merand Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Merand Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
AG
Anthony GiordanoCEO
BH
Brian H. Annex, M.D.Named on SEC filing
AI
Alan I. AnnexVice President & Secretary
Reported raises · per SEC filings
Form D private placements$1.1M disclosed across 1 round · 2019
▶$1.1MraisedJul 2019 · 11 investors · PharmaceuticalsRule 506(b)
▶$1.1MraisedJul 2019 · 11 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Alan I. AnnexExecutive Officer, Director, Promoter
- Anthony GiordanoExecutive Officer, Director
- Brian H. Annex, M.D.Executive Officer, Director
- Offering amount
- $1.3M
- Amount sold
- $1.1M
- First sale
- Jul 2019
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Merand Pharmaceuticals raised?
- Merand Pharmaceuticals has disclosed $1.1M raised across 1 round.
- Where is Merand Pharmaceuticals headquartered?
- Merand Pharmaceuticals is headquartered in Charlottesville, US.